Format

Send to

Choose Destination
Int J Mol Med. 2018 Apr;41(4):1799-1808. doi: 10.3892/ijmm.2018.3411. Epub 2018 Jan 22.

β-glucans and cholesterol (Review).

Author information

1
Laboratory of Immunotherapy, Institute of Microbiology of The Czech Academy of Sciences, 14220 Prague 4, Czech Republic.
2
Department of Pathology, University of Louisville, Louisville, KY 40202, USA.

Abstract

Hypercholesterolemia is one of primary risk factors of cardiovascular disease, together with metabolic syndrome, hypertension and diabetes. Although progress has been made, the search for novel methods of preventing and treating dyslipidemia is ongoing and current therapies for cardiovascular disease induce various side effects. β‑glucans are linear unbranched polysaccharides found in various natural sources, such as mushrooms. Due to their structure they are able to interact with innate immunity receptors, however they also act as dietary fibers in the digestive tract. As there are two forms of β‑glucans, insoluble and soluble forms, they are able to interact with lipids and biliary salts in the bowel and consequently reduce cholesterol levels. Therefore, they may be developed as a suitable therapeutic option to treat patients with dyslipidemia, as they are natural molecules that do not induce any significant side effects. The current review discusses the evidence supporting the effects of β‑glucans on cholesterol levels.

PMID:
29393350
PMCID:
PMC5810204
DOI:
10.3892/ijmm.2018.3411
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Spandidos Publications Icon for PubMed Central
Loading ...
Support Center